The use of serotonin reuptake inhibitors increases the risk of bleeding in patients with assist devices

BACKGROUND: Bleedings are frequent and dreaded complications in heart failure patients with ventricular assist devices (VAD). Serotonin reuptake inhibitor (SRI) antidepressants are widely used to treat depression in these patients, though they are attributed an increased risk of bleeding due to thei...

Descripción completa

Detalles Bibliográficos
Autores principales: Auschra, Bianca, Wilhelm, Markus J., Husung, Claudia, Jenewein, Josef, Flammer, Andreas J., Jellestad, Lena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939197/
https://www.ncbi.nlm.nih.gov/pubmed/35317724
http://dx.doi.org/10.1186/s12872-022-02557-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939197/
https://www.ncbi.nlm.nih.gov/pubmed/35317724
http://dx.doi.org/10.1186/s12872-022-02557-1

Ejemplares similares